Status:
UNKNOWN
The Association of Endothelial Dysfunction and Cardiac Allograft Vasculopathy
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Heart Transplantation
Eligibility:
All Genders
20-80 years
Brief Summary
Progressive cardiac allograft vasculopathy (CAV) is a serious complication in long-term survivors after heart transplantation. Therefore, we hypothesize that CAV is a diffuse and progressive process, ...
Eligibility Criteria
Inclusion
- 1\. Heart transplant receipients who undergoing the coronary angiographic follow-up as standard protocols.
Exclusion
- Acute illness conditions including infection, congestive heart failure (NYHA Fc III, IV), etc.
- Coronary angiographic finding: coronary stenosis\>30% (as grade III, IV by Klauss V et al, Am J Cardiol 1995; 76:463-6).
- Creatinine \>3.0 mg/dl
Key Trial Info
Start Date :
March 1 2003
Trial Type :
OBSERVATIONAL
End Date :
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00173914
Start Date
March 1 2003
Last Update
September 15 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan